Danielle Geiger, APRN
Nurse Practitioner · Omaha, NENPI 1598735763
Payments from drug & device makers
Across 46 payments — averaging $103.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$979
- Avyxa Pharma, LLC$800
- ASD Specialty Healthcare, LLC$754
- E.r. Squibb & Sons, L.L.C.$644
- AstraZeneca$480
- EMD Serono, Inc.$207
- plus $887 from 13 others
What the payments were for
- Consulting fees$1,96441%
- Speaking & faculty fees$80017%
- Food & beverage$1,78938%
- Education$1994%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 2 | $979 |
| Avyxa Pharma, LLC | 1 | $800 |
| ASD Specialty Healthcare, LLC | 10 | $754 |
| E.r. Squibb & Sons, L.L.C. | 1 | $644 |
| AstraZeneca | 4 | $480 |
| EMD Serono, Inc. | 2 | $207 |
| Sanofi | 4 | $172 |
| Ipsen Biopharmaceuticals, Inc | 1 | $113 |
| Genentech, Inc. | 3 | $107 |
| Seagen Inc. | 1 | $100 |
| Gilead(2 entities) | 3 | $98 |
| Amgen | 4 | $74 |
| Pfizer | 3 | $61 |
| AbbVie | 2 | $48 |
| Merck | 1 | $33 |
| Siemens Medical Solutions USA, Inc. | 1 | $24 |
| Novartis | 1 | $22 |
| Verity Pharmaceuticals Inc. | 1 | $20 |
| CTI Biopharma Corp. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,752 in reported general payments places this provider in the 90th percentile of 924 nurse practitioner providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Omaha
- Kristen HammesOmaha$899K
- Amy MuchowiczOmaha$78K
- Kari CunninghamOmaha$53K
- Laura DonovanOmaha$49K
- Kathleen HealeyOmaha$36K
- Katie RuchOmaha$26K
- Amanda GuggenmosOmaha$23K
- Amy YagerOmaha$15K
- Cara SchiesslerOmaha$14K
- Lindsay OneilOmaha$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.